Stocktoria
Cronos Group Inc. CRON
Nasdaq · XNAS · stock · Medicinal Chemicals & Botanical Products · website · IPO 2014-05-07
Cronos Group Inc. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $193.4M | $161.8M | $120.3M | $109.3M | $79.6M |
| Gross profit | $62.8M | $25.2M | $11.9M | $15.4M | -$17.6M |
| R&D expense | $4.4M | $4.2M | $5.8M | $13.1M | $21.8M |
| Operating income | -$17.4M | -$76.5M | -$84.8M | -$111.4M | -$292.0M |
| Interest expense | — | — | — | $13,000 | $27,000 |
| Income tax | -$14.2M | -$3.4M | -$3.2M | $34.2M | -$431,000 |
| Net income | -$9.4M | $41.1M | -$74.0M | -$168.7M | -$396.1M |
| EPS (diluted) | $-0.02 | $0.11 | $-0.19 | $-0.45 | $-1.07 |
| Operating cash flow | $25.9M | $18.8M | -$42.8M | -$88.9M | -$153.6M |
| Free cash flow | $149,000 | $6.4M | -$45.3M | -$92.4M | -$164.8M |
| Cash & equivalents | $791.8M | $858.8M | $669.3M | $764.6M | $887.0M |
| Inventory | $46.8M | $33.1M | $30.5M | $37.6M | $32.8M |
| Total assets | $1.2B | $1.2B | $1.1B | $1.2B | $1.4B |
| Total liabilities | $54.2M | $55.3M | $44.1M | $72.0M | $63.5M |
| Shareholders' equity | $1.1B | $1.1B | $1.1B | $1.1B | $1.3B |
Source: SEC EDGAR filings · CIK 0001656472 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.